BeautyHealth Announces Robust Q4 2024 Performance, Driven by HydraFacial Growth
The Beauty Health Company (NASDAQ: SKIN), the powerhouse behind the renowned HydraFacial brand, reported robust financial results for Q4 2024. The company proudly announced fourth quarter net sales reaching $83.5 million and an impressive full year net sales of $334.3 million. A significant milestone was achieved with the installation of over 35,000 HydraFacial devices globally.
The company’s CEO emphasized the escalating consumer demand for clinically proven skin health treatments. The HydraFacial brand continues to exhibit strong market leadership. In addition, the company launched innovative new products, such as the HydraFillic with Pep9™ Booster. This product marks a revolution in peptide-powered, non-invasive skin health treatments, specifically targeting fine lines and wrinkles.
BeautyHealth’s success is a testament to the vigorous growth observed in the professional skincare device market. Consumers are increasingly opting for clinical-grade treatments. The company’s achievement of installing 35,000 devices worldwide reflects HydraFacial’s compelling value proposition to both providers and consumers in the burgeoning aesthetic treatment industry. This growth trajectory firmly positions BeautyHealth as a forerunner in the integration of beauty and medical aesthetics.
For more information, visit the official BeautyHealth news release.